IGI Logo

Prevest Denpro is currently trading at Rs. 353.95, up by 27.90 points or 8.56% from its previous closing of Rs. 326.05 on the BSE.

The scrip opened at Rs. 377.00 and has touched a high and low of Rs. 377.00 and Rs. 336.60 respectively. So far 8000 shares were traded on the counter.

The BSE group 'M' stock of face value Rs. 10 has touched a 52 week high of Rs. 478.15 on 04-Jan-2022 and a 52 week low of Rs. 170.65 on 01-Oct-2021.

Last one week high and low of the scrip stood at Rs. 377.00 and Rs. 290.00 respectively. The current market cap of the company is Rs. 408.34 crore.

The promoters holding in the company stood at 73.60%, while Institutions and Non-Institutions held 2.00% and 24.40% respectively.

Prevest Denpro has received U.S. Food and Drug Administration’s (USFDA) clearance for four of its products falling in the category of Dental Cavity Liners. Prevest DenPro is the first Indian dental manufacturer who has received USFDA clearance for its products. The products which have been recently cleared in the category of Cavity Liners are CalUltra, Cal LC, Apacal ART and Calcigel. All these products are calcium hydroxide based cavity liners, highly useful for endodontic treatment worldwide.

With the approval of these products company’s product portfolio has widened and company has better marketing prospects in the USA market. As an organization committed to expand its market globally, this approval will enable to serve the international market especially US Market with a bigger product portfolio. The approval is also an endorsement of commitment to comply with global manufacturing standards and regulations.

Prevest Denpro manufactures and markets a range of dental materials for diagnosing, treating, and preventing dental conditions and improving the aesthetics of the human smile.